Photo from wikipedia
Ticagrelor is an antiplatelet agent used for treatment of coronary artery disease via inhibition of the P2Y12 receptor. Based on limited literature the safety of intravenous thrombolysis for ischemic stroke… Click to show full abstract
Ticagrelor is an antiplatelet agent used for treatment of coronary artery disease via inhibition of the P2Y12 receptor. Based on limited literature the safety of intravenous thrombolysis for ischemic stroke in patients with ticagrelor pretreatment is unknown. We present two patients established on ticagrelor treated with intravenous thrombolysis for acute ischemic stroke complicating coronary intervention.
Keywords:
thrombolysis ischemic;
intravenous thrombolysis;
ischemic stroke;
patients ticagrelor
Journal Title: Journal of Clinical Neuroscience
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Neuroscience
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!